Selectable stable pluripotency reporter hPSC lines in pluripotency and differentiation
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Introduction:
Human embryonic stem (ES) and induced pluripotent stem (iPS) cells are expected to revolutionize regenerative medicine and are potentially powerful tools for therapeutic drug screening (Inoue, H. and Yamanaka, S., 2011; Rowntree, R.K. and McNeish, J.D., 2010) . Despite recent rapid advances in our ability to expand these cells as pluripotent cells (Ungrin, M.D. et al., 2008) and direct their differentiation into a range of desired cell lineages (Keller, G., 2005) , much is to be learned about the extrinsic and endogenous factors produced that control these processes, and how these are modulated by cell-cell contact signalling and other features of the microenvironment. The ability to genetically manipulate mouse ES cells and the generation of mouse models with constitutive or inducible tissuespecific, cell-specific or gene-specific fluorescent reporters has greatly accelerated our understanding of pluripotent stem cell biology. However, in the case of human pluripotent cells the development of such tools has been much slower, mainly because of the inefficient nature of homologous recombination in human pluripotent cells, the difficulty in obtaining clonal populations of cells, and their inherent genetic and epigenetic instability in culture. The derivation of transgenic, clonal, and karyotypically normal human pluripotent stem cell lines is therefore a non-trivial endeavour.
Furthermore, there is the obvious inability to perform human blastocyst injection of geneticallytagged ES cells, an assay that is widely used in mice to exemplify the efficacy of ES and iPS cell reporters. Given the intrinsic differences between mouse and human ES cells in terms of molecular pathways maintaining pluripotency and inducing lineage-specific differentiation, and the need to isolate pure populations of lineage-specific progenitors (or the identification of specific cell surface markers thereof), a number of laboratories have undertaken the arduous task of genetically tagging promoters and genes of interest using either classical homologous recombination or zinc finger/TALEN-based genome editing techniques (Liu, Y. et al., 2011; Zou, J. et al., 2009; Zwaka, T.P. and Thomson, J.A., 2003) . It is, however, becoming increasingly clear that human embryonic stem cell lines differ intrinsically in their ability to grow and respond to pluripotent cell culture conditions and also possess different biases in their propensity to undergo differentiation into specific cell types (Lepski, G., 2012) . This is most evident when comparing human iPS cell lines derived from different cell types or generated through different methods (Alvarez, C.V. et al., 2012) . Understanding and harnessing these different propensities of human pluripotent cell lines, properties most likely influenced by both genetic background and epigenetic parameters, is one of the major current challenges in the stem cell field (Tobin, S.C. and Kim, K., 2012) .
With the recent advent of iPS cells and their wide potential in the field of regenerative medicine, the propensity of differentiated, iPS-derived cells to revert back to a pluripotent phenotype is particularly topical (Pera, M.F., 2011) . Hence, the ability to identify, and ultimately eliminate, the cells that retain these undesired pluripotent properties after directed differentiation will be essential for regenerative medicine. One of the most viable and attractive approaches to this end is the genetic tagging of cells which, in turn, requires the identification of the best promoters capable of reporting on such cells.
There is thus a clear need for tools that allow for the rapid and facile delivery of gene reporters to human pluripotent stem cells that faithfully report on pluripotency and differentiation. Lentiviral delivery of fluorescent promoter reporters is clearly an attractive solution, and a family of selectable
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fluorescent reporter lentiviruses has been described by Hotta et al. (Hotta, A. et al., 2009a; Hotta, A. et al., 2009b) . Various promoters have been trialled for their ability to drive expression specifically in pluripotent cells, and the artificial OCT4/POU5F1 promoter sequences-based promoter driving expression of both EGFP and puromycin N-acetyltransferase (conferring puromycin resistance), used in this study, appears to provide the highest efficiency and specificity in human pluripotent ES (hES and iPS) cells (Hotta, A. et al., 2009a ). Here we report on the generation and verification of the pluripotent stem cell lines with the lentivirally-delivered EOS(C3+)-EGFP-IRES-PURO transgene that both reports on pluripotency and, of key importance, allows for the selection of pluripotent stem cells.
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Materials and Methods
Pluripotent and differentiated cell culture conditions and cell lines
hES and iPS cells were cultured in feeder-free conditions in xeno-free defined medium, mTeSR TM 1 (StemCell Technologies, Vancouver, BC) or NutriStem (Stemgent) on Matrigel™ (BD Biosciences at 1/100 dilution) coated tissue culture plastic surfaces. NutriStem medium was supplemented with 10 ng/mL FGF2 (Invitrogen/Life Technologies) for hES and 50 ng/mL for iPS cell line propagation.
Cells were passaged as clumps using dispase (Gibco/Life Technologies) digestion at 1.5 mg/mL. For a typical 2D differentiation protocol, cells were grown in a 6-well plate to ~50% confluence in the presence of 2 µg/mL of puromycin, and the medium changed to selection-free KSR medium (Chung, T.L. et al., 2010) , with or without inducers of differentiation, either 10% FCS or 5 µM retinoic acid (RA). Cells were harvested at 2-6 days after induction of differentiation. HES3 and H9 hES cell lines were provided by the UQ AIBN StemCore (www.stemcore.com.au). The UQEW01i-epifibC11 iPS episomally-derived cell line (referred to as WT11TF for brevity from now on) was described previously (Briggs, J.A. et al., 2012; Nayler, S. et al., 2012) . At least three independent clones from hES and iPS parental cell lines with representative characteristics (levels of reporter expression in pluripotent state, reporter inactivation dynamics) were used for analysis.
Lentiviral transduction of the pluripotent stem cells
Lentiviral and packaging vectors, pCMVR8.2 and pVSV-G, were co-transfected into the 293FT cell line (Invitrogen) for viral particle production as described in (Whitworth, D.J. et al., 2012) . HES3 and H9 hES cells adapted to passaging as a single-cell suspension, as described previously (Hudson, J. et al., 2012) , as well as the hESC and UQEW01i-epifibC11 lines maintained as bulk cultures on 
Analysis of the reporter and pluripotency marker expression
2.3.1 Flow cytometry: Analysis of cell surface markers was carried out essentially as described in Whitworth, D.J. et al., 2012 
identical concentrations as the primary antibodies were used to set the gates. Flow cytometry data were collected using BD LSRII or AccuriCFlow C6 cytometers, and analysed using AccuriCFlow. thus providing high confidence in the significance of the correlation (p<0.01).
Reporter cell line evaluation in multifactorial microbioreactor array-based assays
Data from full-factorial microbioreactor array screening experiments using a previously described system (Hudson, J. et al., 2012) were used to compare EOS-GFP expression with TG30 and TRA-1-60 expression levels. Briefly, microbioreactors were fabricated and sterilised, surface-coated with 400 μg/mL purified human fibronectin (BD Biosciences), and seeded with HES3::EOS ( 
by I EOS-GFP = (T EOS-GFP -μ EOS-GFP )/σ EOS-GFP ,
where I EOS-GFP is termed the expression index of EOS-GFP, and μ EOS-GFP is the mean and σ EOS-GFP the standard deviation of all spot intensities (T EOS-GFP )for a particular array.
Assessment of the differentiation potential of the pluripotency reporter cell lines
The differentiation potential of EOS(C3+)-EiP cell lines was assessed using both in vitro embryoid body formation and in vivo teratoma formation assays. For embryoid body formation, cells were digested using dispase with subsequent resuspension in KSR medium (20% KnockOut TM Serum
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Replacement in DMEM/F12 medium, (both from LifeTechnologies), full description in (Chung, T.L. et al., 2010) , in a well of a 6-well ultra-low attachment polystyrene plate (Falcon). For the teratoma formation assay, a pellet of 5x10 5 cells was formed in the presence of Matrigel matrix at 1:50 dilution, and injected intramuscularly into the thigh muscle of a NOD/SCID mouse. Teratomas were harvested within 4-8 weeks, fixed and processed for paraffin embedding and histological analysis.
Haematoxylin/eosin-stained 5 μm sections were permanently mounted, microscopically analysed and imaged on an Olympus IX51 inverted microscope equipped with MicroPublisher 3.3 RTV CCD camera (QImaging). For directed differentiation, we utilized previously described protocols for neuronal (Briggs, J.A. et al., 2012) differentiation from the hPSCs.
Analysis of the pluripotency and lineage-specific marker expression in embryoid bodies derived from EOS(C3+)-EiP human pluripotent cell lines
Downregulation of the expression of the conventional markers of pluripotency (POU5F1 and SOX2) and selected markers of differentiation into the three major germ layers and their derivatives (PAX6, EOMESODERMIN and CDX2) were assayed using a qPCR-based approach. Briefly, total RNA was isolated using the Nucleospin RNA II kit (Macherey-Nagel) according to the manufacturer's protocol.
1 μg of isolated total RNA was utilized to synthesize cDNA using the iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer's protocol. qPCR reactions comprised of Ssofast Evagreen (Bio-Rad) reaction mix and cDNA template were performed using the C1000 Thermal Cycler (BioRad). All measured genes had their corresponding quantitative levels normalized to endogenous GAPDH. Primer sequences can be found in Table 1 .
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Results
Generation and characterisation of EOS reporter lines
Human embryonic stem cell lines HES3 and H9 and the non-viral, integration-free human iPS cell line WT11TF (UQEW01i-epifibC11 (Briggs, J.A. et al., 2012) ) were cultured under feeder-free conditions in mTeSR TM 1 or MEF-conditioned medium, and transduced with high titre lentiviral preparations produced using the EOS(C3+)-EGFP-IRES-PURO (from this time referred to as EOS(C3+)-EiP) constructs (Hotta, A. et al., 2009a) . By day 5, up to 5 % of hES/iPS cells were found to express GFP. Such cultures were next allowed to expand for 3 more days before selection for stable integration of the transgene through the addition of initially 2 µg/ml puromycin, with a further increase to 2.5 µg/ml puromycin after day 6. After 12-16 days, we observed an almost homogeneous expression of EGFP in some colonies of surviving hESC and iPSC (Supplementary figure 1F) . These colonies were next harvested, expanded and cryopreserved. During continued passaging of EOS(C3+)-EIP hES and iPS cells we observed the well-known sporadic inactivation of lentiviral transgenes previously observed in hPSCs (Liew, C.G. et al., 2007; Xia, X. et al., 2007) (Table 2) . When under constant selection, the fraction of EGFP-expressing resistant cells in single cell-derived clones was found to be consistently high in all hPSCs, specifically 90.14 ± 3.2% (5 clones) for HES3 hESC and 93.5 ± 2.7% (5 clones) for WT11TF iPSC (also see Table 1 (Fig 1 I-J) , such as those typically occurring at the centres of hES and iPS colonies.
Enrichment for pluripotent cells improves directed differentiation protocols
Because differentiated cells excrete paracrine factors and impose confounding cell-cell interactions on human pluripotent stem cells, homogeneous and efficient differentiation protocols generally require (or at least greatly benefit from) a pure pluripotent starting population, e.g. (Hudson, J. et al., 2012) .
The presence of the EOS promoter-driven puromycin antibiotic selection marker allows for a rapid deletion of any differentiated cells from such cultures (e.g. Fig 1K where the EGFP-IRES-puro
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cassette is driven by a ubiquitous PGK promoter compared to a colony in Fig 1L utilising the EOS(C3+) promoter). Nearly-complete ablation could be achieved in as little as 2-3 days due to the potent nature of the puromycin selection, causing rapid death and detachment of non-resistant cells (Supplementary Figure 1L and data not shown).
To exemplify the benefits of this selection, we cultured three WT11TF::EOS(C3+)-EiP clones for 3 weeks in parallel in conditioned medium containing 50 ng/mL bFGF with and without puromycin selection. Subsequent flow-cytometric analysis showed that the antibiotic-selected population contained 1.7 ± 0.5% of POU5F1/OCT4 -cells (N=3) while the similarly cultured non-selected populations contained 9.3 ± 2.3% (N=3) POU5F1/OCT4 -cells ( Figure 2H ). We next assessed whether this difference in starting population affects the efficiency of neuronal differentiation (See Methods section). Indeed, after 6 days of directed neuronal differentiation, puromycin-selected cultures displayed 31 ± 4.2% PAX6+ neuroepithelial progenitors, as measured by flow cytometry with anti-PAX6 antibody, whereas unselected cultures show 20 ± 5.1% PAX6+ cells (N=3, Figure 2H and Supplementary Figure 2D ).
Validation of the functionality of the pluripotency reporter lines
In time-lapse videos of differentiating colonies of the reporter clones a very good concordance between the EGFP extinction and morphological changes associated with differentiation is apparent and iPS-derived (Supplementary Figure 3) reporter clones. Downregulation of the reporter followed the decrease in levels of OCT4 protein with a ~24 hours lag period resulting in a population of cells with reduced OCT4 expression but still retaining detectable levels of EGFP reporter protein expression ( Figure 3C ). This observation is consistent with the stability of the EGFP mRNA (Cubitt, A.B. et al., 1995) , the half-life of EGFP protein of around 26 hours in mammalian cells (Corish, P. and Tyler-Smith, C., 1999) and the fact that OCT4 is itself is a direct regulator of the reporter promoter.
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Flow-cytometric analysis revealed a high concordance between EGFP expression and expression of pluripotency cell surface markers such as TRA-1-60 and SSEA-4 (representative raw data plots shown for TRA1-60 in Figure 3B , and for SSEA4 in Supplementary Figure 3A) . Figure 3A and data not shown).
Collectively these data demonstrate that EGFP expression in lentivirally-generated hESC and hiPSC EOS(C3+)-EiP pluripotency reporter lines faithfully and dynamically reports on pluripotency and that such lines behave as normal human pluripotent cell lines.
Pluripotency screening in a multifactorial microbioreactor array
The pluripotency reporter cell line HES3:EOS-C(3+)-EiP was seeded into the microbioreactor array for all 3 pluripotency markers occurred at Column 25 (100 ng/mL FGF2, 0.5 ng/mL TGFβ1), which corresponds to reconstituted composition of original mTeSR TM 1 maintenance medium.
TRA-1-60 exhibited a lower dynamic range than EOS(C3+)-EIP, and had higher residual expression, resulting in "false-positive" readouts in pluripotency non-maintaining environments in some differentiating conditions in the array ( Figure 3D and figure legend, and Figures 3C and Supplementary Figure 2) . As a result of this, levels of TRA-1-60 expression, both when normalized across the microbioreactor ( Figure 3E ) or against the chamber's DNA contents (data not shown), varied more widely than EOS(C3+)-EIP and thus were less sensitive as an indicator of differentiation, while the reporter expression appeared to correlate well with the conditions favouring maintenance of pluripotency, and showed robust down-regulation in all RA-containing environments ( Figure 3E ).
Persistence of the EOS(C3+)-EIP reporter uncovers heterogeneity amongst embryoid bodies in differentiation assays
To investigate extinction dynamics of the pluripotency reporter in a 3D setting, we next subjected hESC and iPSC reporter lines to embryoid body (EB) differentiation protocols. Conventional analysis of lineage-specific marker expression on pooled EBs after 8 weeks shows the expected overall
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decrease in expression of both OCT4/POU5F1and SOX2, and up-regulation of the neuronal (PAX6, TUBB3), posterior endoderm (CDX2) and mesoderm (EOMESODERMIN) lineage markers that is routinely reported in the literature (Supplementary figure 2) . However, in situ examination of EGFP expression in EOS(C3+)-hESC and iPSC reporter clone derived suspension EBs revealed an unexpected persistence and remarkable inter-EB diversity (Figure 4 A-F). While there was a marked and expected overall downregulation of reporter expression after 2 weeks in culture when compared to freshly generated EBs ( Figure 4C ), a large proportion of the EBs retained low levels of EGFP expression ( Figure 4C ,C'). After 6 weeks of suspension culture in KSR medium without pluripotencymaintaining factors a number of EBs (~70%, increasing with time in culture) lost all, or most, of the EOS(C3+)-EIP reporter-driven EGFP fluorescence ( Figure 4F ). These EBs were typically smaller, and started to form cavities or cyst-like structures (Supplementary Figure 4B,C) . Pooling of the 6 week-old EGFP-low and EGFP-negative EBs followed by a qPCR analysis revealed that EBs retaining reporter fluorescence maintained higher levels of residual OCT4/POU5F1 (tested using 2 distinct qPCR primer sets), its downstream target LEFTYA, and higher levels of the mesodermal marker EOMESODERMIN (Supplementary Figure 4A) . On the other hand, low EGFP-expressing
EBs showed similar expression levels of SOX2 (a direct regulator of the EOS promoter, also tested using 2 distinct qPCR assays, one of which is shown in Supplementary Figure 4A ), DNMT3A (a pluripotency-associated DNA methyl-transferase), PAX6 (a neuroectodermal marker) and TUBB3 (a neuronal marker) (Supplementary Figure 4A) . By week 12 virtually no EGFP expression was detected in any of the EBs ( Figure 4F , Supplementary Figure 4C ,D), indicating that this persistence of EGFP expression in a subset of 6 week-old EBs that appears to undergo mesodermal differentiation is not due to an intrinsic inability to down-regulate the reporter. Identification of this unexpected heterogeneity within EB pools would not have been possible without the use of the pluripotency reporter and is one example of its utility.
Discussion
The ability for live monitoring of the pluripotency status of stem cells is important for both optimisation of growth and differentiation conditions, and assessment of the retention and extinction of pluripotency by stem cell lines, in particular iPSCs, during differentiation. The EOS promoter tested is available in 2 variants, with tandemly concatenated OCT4/SOX2 binding sites derived from either the OCT4/POU5F1 promoter (C3, 3 copies) or SOX2 promoter (S4 variant, 4 copies) (Hotta, A. et al., 2009a; Hotta, A. et al., 2009b) . Clonally-derived hES lines were originally generated using both variants, but preliminary analysis showed that the former (C3+) variant tended to produce lines with more consistent reporter expression and responsiveness across a wider range of basal fluorescence levels, and produced a larger fraction of puromycin-resistant clones that were EGFP + (78% vs. 62%, n=50 for HES3).
It is likely that a pluripotency reporter construct could be a useful tool to drive "suicide gene"-based cassettes and delete unwanted stem cells that either retain or re-acquire pluripotency in iPSC-derived grafts. In this study we show that the reporter is rapidly extinguished during various directed and spontaneous differentiation protocols, with more efficient extinction in neurally-biased embryoid body differentiation, but can maintain residual expression for extended periods in cells that differentiate into embryoid bodies biased towards the mesodermal lineage. Reporter expression is eventually lost in the majority of cellular aggregates (EBs) after 6 weeks and from all cells after 12 weeks of EB-based differentiation, identifying the time window when such deletion strategies should commence in vivo. One could further envisage that the lentiviral delivery of the reporter to newly generated iPS cell lines could be used as a tool to screen such lines for their propensity to re-acquire pluripotency following differentiation, e.g. as EBs, and study the molecular basis of this unwanted property.
In the shorter term the greatest utility of these lines lies in their ability to report on pluripotency in real time. We exemplify that human pluripotent stem cell lines that stably express the reporter allow monitoring of the pluripotency states of individual cells in a wide spectrum of experimental settings (e.g. Titmarsh, D.M. et al., 2013) . These lines are particularly valuable for microbioreactor arrays, bioengineering applications, and other applications requiring non-intrusive and continuous monitoring regimes such as screening of culture surfaces.
The reporter lines allowed us to observe in real time that colonies with greater than 300 cells displayed slightly higher expression levels of the reporter at the colonies' outermost few cell layers ( Figure 1A , F, fluorescence profiles across colonies shown in Supplementary figure 2M ). This is in agreement with previous observations of higher levels of TGF/activin signalling and higher expression of pluripotency markers on the edges of the human pluripotent stem cell colonies (Hough, S.R. et al., 2009 ).
The ability to efficiently select for cells of a consistently highly-pluripotent phenotype in cultures, including those on a large scale, is crucial for providing homogeneously-pluripotent starting material for directed differentiation protocols, for instance in the generation of cardiomyocytes and certain neuronal cell types.
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We demonstrate that removal of the puromycin selection causes the emergence of a population of differentiated, OCT4-negative cells ( Figure 2H ). It appears that these spontaneously-differentiated cells have a cell non-autonomous effect on the directed neuroepithelial conversion of the whole population, resulting in a 33% drop in the numbers of neuroectodermally-converted cells as measured by the expression of PAX6 protein ( Figure 2H and Supplementary Figure 2D) .
The difference in correlation between EGFP and TRA160 as compared to that between EGFP and SSEA4 or TG30 is consistent with the observations that extinction dynamics of TRA-1-60 with differentiation are substantially faster than that of TG30 or SSEA4 ( Figure 3D and supplementary   figure 2 ). The dynamic response range and sensitivity of the EOS(C3+)-EGFP-IRES-Puro reporter is in fact superior to TRA-1-60, as can be judged from the more rapid and pronounced downregulation of EGFP than TRA-1-60 following RA-induced differentiation ( Figure 3D and Supplementary Figure   2C ). Similarly, when titrating concentration combinations of FGF2 and TGF1, the expression of reporter EGFP corresponded much more dynamically to variations in these pluripotency-maintaining factors than TRA-1-60 ( Figure 3E ).
In conclusion we have generated and characterized multiple hES and iPS cell lines that should prove a useful tool for exploration of the maintenance of pluripotency, pluripotency extinction and reemergence in real time, enabling simple and scalable selection of hPSC populations that are near homogeneously pluripotent, and undergo more homogeneous and efficient directed differentiation . A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT Figure 4 . Use of the EOS reporter reveals heterogeneity within pools of spontaneouslydifferentiating embryoid bodies (EBs). A. Fluorescent image of representative EBs 2 days after formation. B. EBs 1 weeks after formation retain high levels of EOS(C3+)-EiP reporter fluorescence. C, C'. Fluorescent and bright-field images of EBs 2 weeks into differentiation, when a number of EBs (<10%) fully inactivate the reporter. D, D'. Representative images of both types of EBs at 6 weeks of differentiation that clearly retain (EGFP+) or extinguish (EGFP-) the reporter expression in majority of their cells, and were used for the differential expression analysis. E, E'. By 8 weeks, only low level of EGFP expression persists in some of the EBs, and virtually all expression is lost by week 12 (See Supplementary Figure 4) . F. Representation of the quantification of EGFP+ and EGFP-fractions in iPSC-reporter derived EBs. Scored EB number N>40 for each time point. G. qPCR analysis of the expression of pluripotency marker POU5F1/OCT4, and mesodermal (EOMESODERMIN) and neuroepithelial (PAX6) markers in EGFP + and EGFP -EBs at 6 weeks. Persistence of EGFP correlates with high levels of residual POU5F1/OCT4 expression. See Discussion for more detail. Data for all genes is normalised against the internal GAPDH control, error bars-SEM values (N=3). Scale bar = 500µm. A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 
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